We are live on
!
Find out more
CA
Cambridge Advisors Portfolio holdings
AUM
$582M
Turnover
4.86%
1-Year Est. Return
19.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.91%
1 Year Est. Return
+19.14%
3 Year Est. Return
+52.94%
5 Year Est. Return
+51.55%
10 Year Est. Return
+171.25%
AUM
$373M
AUM Growth
+$23.6M
(+6.8%)
Cap. Flow
-$1.94M
Cap. Flow
% of AUM
-0.52%
Top 10 Holdings %
Top 10 Hldgs %
53.12%
Holding
186
New
12
Increased
38
Reduced
87
Closed
5
Avg Time Held
4.9
years
Top 10 Avg Time Held
6
years
Top 20 Avg Time Held
5.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FT Vest US Equity Enhance & Moderate Buffer ETF December
XDEC
|
+$900K |
| 2 |
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
|
+$536K |
| 3 |
FT Vest US Equity Deep Buffer ETF May
DMAY
|
+$444K |
| 4 |
Innovator Power Buffer Step-Up Strategy ETF
PSTP
|
+$405K |
| 5 |
Innovator Growth-100 Power Buffer ETF October
NOCT
|
+$266K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$950K |
| 2 |
Gilead Sciences
GILD
|
+$586K |
| 3 |
Weyerhaeuser
WY
|
+$571K |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$401K |
| 5 |
Microsoft
MSFT
|
+$377K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 76.1% |
| 2 | Technology | 7.14% |
| 3 | Healthcare | 6.36% |
| 4 | Industrials | 2.9% |
| 5 | Financials | 2.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Innovator Defined Wealth Shield ETF
BALT
$3.11B
| $266K | 0.07% |
10,000
| – | – |
2022 Q2
2 quarters
|
|
|
152
Gilead Sciences
GILD
$194B
| $265K | 0.07% |
3,090
-7,400
| -71% | -$586K |
2014 Q4
32 quarters
|
|
|
153
Innovator Growth-100 Power Buffer ETF October
NOCT
$271M
| $263K | 0.07% |
+7,500
| New | +$266K |
2022 Q4
0 quarters
|
|
154
Charles River Laboratories
CRL
$14.3B
| $261K | 0.07% |
1,200
| – | – |
2017 Q2
22 quarters
|
|
155
Clorox
CLX
$10.5B
| $261K | 0.07% |
1,860
| – | – |
2014 Q4
32 quarters
|
|
156
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.8B
| $260K | 0.07% |
6,677
| – | – |
2021 Q2
6 quarters
|
|
157
iShares MSCI Intl Quality Factor ETF
IQLT
$13.7B
| $260K | 0.07% |
8,012
-1,138
| -12% | -$35.4K |
2021 Q1
7 quarters
|
|
158
VanEck Semiconductor ETF
SMH
$65.8B
| $259K | 0.07% |
2,556
-456
| -15% | -$46.4K |
2021 Q2
6 quarters
|
|
159
Simplify US Equity PLUS Downside Convexity ETF
SPD
$101M
| $255K | 0.07% |
10,527
-1,951
| -16% | -$49.2K |
2021 Q3
5 quarters
|
|
160
Fortive
FTV
$17.5B
| $252K | 0.07% |
5,204
| – | – |
2016 Q3
25 quarters
|
|
161
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.17B
| $252K | 0.07% |
2,043
-293
| -13% | -$37.2K |
2019 Q1
15 quarters
|
|
162
FT Vest US Equity Deep Buffer ETF February
DFEB
$449M
| $248K | 0.07% |
7,441
| – | – |
2020 Q1
11 quarters
|
|
163
Carrier Global
CARR
$45.3B
| $248K | 0.07% |
6,001
| – | – |
2020 Q4
8 quarters
|
|
164
VanEck Junior Gold Miners ETF
GDXJ
$8.14B
| $242K | 0.07% |
+6,800
| New | +$224K |
2022 Q4
0 quarters
|
|
165
iShares Gold Trust
IAU
$61.8B
| $240K | 0.06% |
6,926
| – | – |
2014 Q4
32 quarters
|
|
166
Innovator US Equity Accelerated 9 Buffer ETF July
XBJL
$77M
| $232K | 0.06% |
9,045
| – | – |
2022 Q3
1 quarter
|
|
167
3M
MMM
$85B
| $232K | 0.06% |
2,309
| – | – |
2014 Q4
32 quarters
|
|
168
iShares US Home Construction ETF
ITB
$2.41B
| $230K | 0.06% |
+3,800
| New | +$219K |
2022 Q4
0 quarters
|
|
169
Adobe
ADBE
$95.4B
| $227K | 0.06% |
+675
| New | +$216K |
2022 Q4
0 quarters
|
|
170
CVS Health
CVS
$118B
| $226K | 0.06% |
2,430
-13
| -0.5% | -$1.25K |
2021 Q2
6 quarters
|
|
171
SLB Ltd
SLB
$73.5B
| $219K | 0.06% |
+4,099
| New | +$204K |
2022 Q4
0 quarters
|
|
172
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$5.92B
| $219K | 0.06% |
+7,600
| New | +$210K |
2022 Q4
0 quarters
|
|
173
First Trust SkyBridge Crypto Industry and Digital Economy ETF
CRPT
$104M
| $211K | 0.06% |
64,090
+32,500
| +103% | +$146K |
2021 Q4
4 quarters
|
|
174
SiriusXM
SIRI
$9.09B
| $207K | 0.06% |
3,546
-586
| -14% | -$36K |
2014 Q4
32 quarters
|
|
175
FT Vest US Equity Enhance & Moderate Buffer ETF September
XSEP
$99.8M
| $205K | 0.06% |
+6,635
| New | +$203K |
2022 Q4
0 quarters
|
|
Similar funds
MIP
LCM
1C
GFI
RIS
MCA
SC
FFG
Cambridge Advisors's Q4 2022 Portfolio in Review
As of Q4 2022, Cambridge Advisors held 186 positions worth $373M, up 6.8% from $349M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Cambridge Advisors's Q4 2022 filing shows 12 new, 38 increased, 87 reduced and 5 closed positions. Its largest new stake was FT Vest US Equity Enhance & Moderate Buffer ETF December: 30,918 shares worth $920K. The largest sale was Vanguard S&P 500 ETF, an estimated $950K.
By sector, the portfolio is most concentrated in Miscellaneous at 76% of assets, down from 76% a quarter earlier, followed by Technology and Healthcare.
- Cambridge Advisors's largest Q4 2022 buy was FT Vest US Equity Enhance & Moderate Buffer ETF December: 30,918 shares worth $920K.
- Cambridge Advisors added most to Schwab US Dividend Equity ETF in Q4 2022, an estimated $223K increase.
- Cambridge Advisors's biggest Q4 2022 reduction was Vanguard S&P 500 ETF, cutting an estimated $950K.
- Cambridge Advisors fully exited Weyerhaeuser in Q4 2022, selling an estimated $571K.
- Cambridge Advisors's ten largest holdings make up 53% of its $373M portfolio in Q4 2022.
- Cambridge Advisors opened 12 new positions and closed 5 in Q4 2022.
- Cambridge Advisors's portfolio value rose 6.8% quarter-over-quarter to $373M.
Based on Cambridge Advisors's 13F filing for Q4 2022, filed 23 Jan 2023.